EMA accepts Luveniq MAA

The European Medicines Agency (EMA) accepted for filing an MAA from Lux Biosciences Inc. (Jersey City, N.J.) for Luveniq voclosporin ( LX211) to treat non-infectious uveitis involving the intermediate...